$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 9, 2025)
$8.25M
Market Cap
-
P/E Ratio
-5.26
EPS
$12.54
52 Week High
$1.53
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
In8bio, Inc. is a New York-based clinical-stage biotechnology firm pioneering the development of innovative cancer therapies through genetically modified gamma-delta T cells. Focused on both autologous and allogeneic cell therapies, the company is strategically targeting solid tumors, thereby establishing itself as a key player in the immuno-oncology space. With a robust pipeline of proprietary treatments, In8bio is committed to meeting critical unmet needs in cancer care, aiming to deliver transformative solutions that could significantly alter the future of oncology therapeutics.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG